ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis.

Kim A Reiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.